Recruiting
Early Phase 1

Immunotherapy & Radiotherapy

Sponsor:

UCLA

Code:

NCT05488366

Conditions

Sarcoma, Soft Tissue

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Radiation therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-01. This information was provided to ClinicalTrials.gov by University of California, Irvine on 2024-08-09.